318 related articles for article (PubMed ID: 22341534)
1. Therapeutic drug monitoring--the appropriate use of drug level measurement in the care of the neonate.
Young TE
Clin Perinatol; 2012 Mar; 39(1):25-31. PubMed ID: 22341534
[TBL] [Abstract][Full Text] [Related]
2. A quality improvement approach to optimizing medication use in the neonatal intensive care unit.
Ellsbury DL; Ursprung R
Clin Perinatol; 2012 Mar; 39(1):1-10. PubMed ID: 22341532
[TBL] [Abstract][Full Text] [Related]
3. Controversial areas of medication therapy for the neonate.
Spitzer AR; Ellsbury DL
Clin Perinatol; 2012 Mar; 39(1):xvii-xviii. PubMed ID: 22341551
[No Abstract] [Full Text] [Related]
4. Drug monitoring in the neonate.
Shipe JR; Herold DA
Ann Clin Lab Sci; 1982; 12(4):296-303. PubMed ID: 7137932
[TBL] [Abstract][Full Text] [Related]
5. Ontogeny and drug metabolism in newborns.
Dotta A; Chukhlantseva N
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
[TBL] [Abstract][Full Text] [Related]
6. Drug studies in newborns: a therapeutic imperative.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Perinatol; 2012 Mar; 39(1):11-23. PubMed ID: 22341533
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring in neonates.
Patrick CH
Neonatal Netw; 1995 Mar; 14(2):21-6. PubMed ID: 7746237
[TBL] [Abstract][Full Text] [Related]
8. Drug disposition in the neonate.
Martin RG
Neonatal Netw; 1986 Feb; 4(4):14-9. PubMed ID: 3633375
[No Abstract] [Full Text] [Related]
9. [Pharmacokinetic studies in neonatology: regulatory and methodologic problems].
Le Guellec C; Autret-Leca E; Odoul F; Jonville Béra AP; Paintaud G
Therapie; 2001; 56(6):663-8. PubMed ID: 11878088
[TBL] [Abstract][Full Text] [Related]
10. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
Besunder JB; Reed MD; Blumer JL
Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
[TBL] [Abstract][Full Text] [Related]
11. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of drugs in neonates: pattern recognition beyond compound specific observations.
Smits A; Kulo A; de Hoon JN; Allegaert K
Curr Pharm Des; 2012; 18(21):3119-46. PubMed ID: 22564304
[TBL] [Abstract][Full Text] [Related]
13. The challenge of managing drugs safely in the newborn.
Jain L
Clin Perinatol; 2012 Mar; 39(1):xv-xvi. PubMed ID: 22341550
[No Abstract] [Full Text] [Related]
14. Pharmacokinetic changes in critical illness.
Boucher BA; Wood GC; Swanson JM
Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
[TBL] [Abstract][Full Text] [Related]
15. Determinants of variability in clearance of exogenous compounds in neonates.
Allegaert K; Van Den Anker JN; Tayman C; De Hoon J
Verh K Acad Geneeskd Belg; 2009; 71(3):141-64. PubMed ID: 20088252
[TBL] [Abstract][Full Text] [Related]
16. [Drug use in a neonatal unit].
Andersen CT; Meberg A
Tidsskr Nor Laegeforen; 1999 Jan; 119(2):197-200. PubMed ID: 10081349
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of amikacin in preterm and term infants.
Siddiqi A; Khan DA; Khan FA; Razzaq A
Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with adverse drug reactions in the newborn.
Aranda JV
Pediatr Pharmacol (New York); 1983; 3(3-4):245-9. PubMed ID: 6429619
[TBL] [Abstract][Full Text] [Related]
19. Neonatal therapeutic drug monitoring--its clinical relevance.
Walson PD; Edwards R; Cox S
Ther Drug Monit; 1989; 11(4):425-30. PubMed ID: 2662479
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in neonatal pharmacotherapy.
Calhoun DA; Murthy SN; Bryant BG; Luedtke SA; Bhatt-Mehta V
Ann Pharmacother; 2006 Apr; 40(4):710-9. PubMed ID: 16569801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
